A recent study found that Ozempic relieves pain, supports weight loss and improves physical activit…

Lars Jørgensen will testify on a solo panel before the Senate Committee on Health, Education, Labor…

Thursday's surge propelled Novo Nordisk to a market cap of $613.3 billion, edging out Tesla's $560.…

Novo Nordisk stock has soared more than 40% year to date as investors cheer the company's weight-lo…

Eli Lilly now sports a market valuation of about $500 billion, making it the ninth largest US compa…

"In February 2011, the U.S. Attorney's Office for the District of Massachusetts served Novo Nordisk…

"The current environment makes it harder to justify the acquisitions, but that's just the part of t…

Novo Nordisk's weight loss drug, Saxenda, helped children ages six to 11 reduce their body mass ind…

Ozempic contains the active ingredient, semaglutide, which helps regulate hunger signals.

Doctors are concerned that a small number of patients on semaglutide are coming in with a form of s…

The FDA warned that incorrect dosing of compounded semaglutide products may be causing health prob…

Physicians warn that weight-loss drugs such as Ozempic and Wegovy come with a risk of severe side e…

People with pre-diabetes who took Zepbound or Mounjaro were 94% less likely to develop the disease,…

Sales of Wegovy more than doubled in the first quarter year on year to $1.3 billion.

While Ozempic could be a game changer for diabetes and obesity, Sanders said its high list price ma…

A woman who started taking a popular weight loss medication through a clinical trial had to look fo…

An analysis found that a stock underperformed the S&P 500 by a median of 7% in the year after being…

David Paton's 50-year-old hit song "Magic" earned him $1 million from use in Ozempic commercials, i…

The anti-obesity drug market will be worth $130 billion by 2030, Goldman Sachs analysts said in a r…

Veteran EU leader Mario Draghi has published a new report outlining the "existential challenge" fac…